LAV portfolio
LAV (Venture capital) is known to hold 80 companies, 12 of them startups. 4 of them are hiring now, with 1,012 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 2 venture rounds in 12 months, raising $106.5M. Most of them work in Oncology Therapeutics, Cell & Gene Therapy, Drug Discovery.
Companies LAV has invested in
Open roles at LAV portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about LAV
How many companies has LAV invested in?
LAV is known to hold 80 companies: 12 startups, and 10 exits so far, read from its own portfolio page and the funding rounds that name it.
Is LAV investing now?
Yes: in the last 12 months 1 rounds in the press named LAV (1 as the lead), and 0 companies joined its portfolio page in 90 days.
What does LAV invest in?
The markets of the companies LAV holds: Oncology Therapeutics (6%), Cell & Gene Therapy (5%), Drug Discovery (4%), Immunology & Inflammation Therapeutics (3%), Precision Medicine (1%).
Which LAV portfolio companies are hiring?
4 companies LAV holds are hiring now, with 1,012 open roles listed on this page.
Who does LAV invest alongside?
The investors that hold the most companies together with LAV: Qiming Venture Partners, OrbiMed, RA Capital Management, Nextech Invest, Sofinnova Investments.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 3; 1 rounds in the press that name it
LAV portfolio: 80 known companies. Alion, Oct 7, 2026. https://alion.io/company/lav-3/portfolio
